and Synflorix, to prevent pneumococcal disease. In 2016, Dr. Slaoui was recognized as one of Fortune's 50 Greatest World Leaders for his work in under-researched diseases common in the developing ...
GlaxoSmithKline has submitted a regulatory application to the European Medicines Agency (EMA) seeking approval of an additional indication for Synflorix in the European Union (EU). This ...